News Remedent, Inc.

Equities

REMI

US75954T1043

Delayed OTC Markets Other stock markets 18:41:52 12/04/2024 BST			5-day change	1st Jan Change
0.055 ^USD	-15.84%		-.--%	-43.30%

2023	Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	CI
2022	Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	11-21	CI
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2022	19/09/22	CI
Remedent : Attorney Letter - Lockett + Horwitz - Remedent, Inc. 2022-06-30 - re Annual Report	30/06/22	PU
Remedent : Annual Report for Year Ended March 31, 2022	30/06/22	PU
REMEDENT, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	30/06/21	AQ
Remedent, Inc. Files Form 15 to Suspend SEC Exchange Act Registration and Applies to Qualify for OTC Markets Alternative Reporting Standard for Pink Sheet Companies	30/06/21	GL
Remedent announces its agreement with Aurum Ceramic Dental Laboratories Co., concerning an Exclusive Master License Agreement in reference to its GlamSmile Veneers and Technology	01/06/21	GL
Remedent Announces Agreement with Aurum Ceramic Dental Laboratories Co., Concerning an Exclusive Master License Agreement in Reference to Its Glamsmile Veneers and Technology	01/06/21	CI
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/02/21	AQ
Remedent, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2020	16/02/21	CI
Remedent, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2020	16/11/20	CI
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/11/20	AQ
Remedent, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2020	14/08/20	CI
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/08/20	AQ
REMEDENT : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	30/06/20	AQ
Remedent, Inc. Reports Earnings Results for the Full Year Ended March 31, 2020	30/06/20	CI
REMEDENT : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/02/20	AQ
Remedent, Inc. Reports Earnings Results for the Third Quarter Ended December 31, 2019	14/02/20	CI
Remedent, Inc. Reports Earnings Results for the Second Quarter Ended September 30, 2019	14/11/19	CI
Remedent, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2019	14/08/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Remedent, Inc.

Equities

REMI

US75954T1043

Summary

Filters